Partner Article
Northwich-based Dechra Pharmaceuticals PLC remains ‘confident’
Competitor stock shortages in the US have meant strong revenues for Northwich-based Dechra Pharmaceuticals.
The manufacturer of veterinary products has reported that group revenue has increased in this quarter by 14.3% at constant exchange rates and 6% at actual exchange rates.
The European part of the business has seen revenues fall at actual exchange rates by 3.3% however sales were positively impacted by wholesalers buying in advance of Easter.
The company said: “ We remain on track to deliver our strategic milestones and further progress has been made in the period“
This was posted in Bdaily's Members' News section by Sophia Taha .
Our Partners
We must forge change to close the skills gap
Creating the conditions for North East talent to thrive
Time to end London monopoly on arts talent
Why local government is key to devolution success
Your reputation is worth more than that invoice
There is no perfect time when selling a business
What next when social media career help goes?
The psychological contract that nobody signs
Time for strategy built on the foundational economy
Why being ‘work-ready’ matters more than ever
The North's future doesn't end at Manchester
Exit or legacy? Why every owner needs a plan